|
|
|
|
| LEADER |
01745nam a2200445 i 4500 |
| 001 |
1356977429 |
| 003 |
OCoLC |
| 005 |
20230106150527.0 |
| 006 |
m o d f |
| 007 |
cr ||||||||||| |
| 008 |
230106s2022 dcu o f000 0 eng c |
| 040 |
|
|
|a GPO
|b eng
|e rda
|e pn
|c GPO
|d MvI
|
| 042 |
|
|
|a pcc
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a COM7
|
| 074 |
|
|
|a 0967 (online)
|
| 086 |
0 |
|
|a J 24.2:X 9
|
| 110 |
1 |
|
|a United States.
|b Drug Enforcement Administration,
|e author.
|
| 245 |
1 |
4 |
|a The growing threat of xylazine and its mixture with illicit drugs :
|b DEA joint intelligence report.
|
| 264 |
|
1 |
|a [Washington, D.C.] :
|b U.S. Department of Justice, Drug Enforcement Administration,
|c 2022.
|
| 300 |
|
|
|a 1 online resource (4 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent.
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia.
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier.
|
| 500 |
|
|
|a "Unclassified."
|
| 500 |
|
|
|a "DEA-DCI-DIR-001-23."
|
| 500 |
|
|
|a GPO Cataloging Record Distribution Program (CRDP).
|
| 588 |
|
|
|a Description based on online resource; title from PDF title page (DEA, viewed Jan. 6, 2023).
|
| 650 |
|
0 |
|a Xylazine
|z United States.
|
| 650 |
|
0 |
|a Drug traffic
|z United States.
|
| 650 |
|
0 |
|a Fentanyl
|z United States.
|
| 856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/gpo190519
|7 0
|
| 907 |
|
|
|a .b66065860
|b cug
|c -
|d 230216
|e 230307
|
| 998 |
|
|
|a cug
|b 230216
|c m
|d a
|e -
|f eng
|g dcu
|h 4
|i 1
|
| 922 |
|
|
|a BIBCONEW
|b 20230106
|
| 922 |
|
|
|a UNREPORTEDPUBSSTAFF
|
| 948 |
|
|
|a MARCIVE Comprehensive, in 2023.03
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2023.03
|
| 995 |
|
|
|a Loaded with m2btab.msgov7 in 2023.02
|
| 989 |
|
|
|a J 24.2:X 9
|d cuege
|e - -
|f - -
|g j
|h 0
|i 0
|j 216
|k 230216
|l $0.00
|m
|n - -
|o -
|p 0
|q 0
|t 0
|x 0
|w US Gov Docs
|1 .i145531028
|